View Recursion Pharmaceuticals, Inc. Class A RXRX stock quote prices, financial information, real-time forecasts, and company news from CNN.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights ...

CBSE Board 12th Result 2026: Around 18.5 lakh students are eagerly awaiting their Class 12 board examination results for 2026. While there has been no official confirmation, several media reports ...

CBSE Class 12 result 2026: The Central Board of Secondary Education will release the CBSE Class 12 result 2026 online, allowing students to access their scores through multiple platforms. The results ...

MPBSE MP Board 10th 12th Result 2026: The Madhya Pradesh Board of Secondary Education (MPBSE) has declared the Class 10 and Class 12 results for 2026 through official online platforms. Students can ...

CBSE Board 10th, 12th Result 2026 Live Updates: The Central Board of Secondary Education (CBSE) is likely to announce the Class 10 board examination 2026 results by April 14. The early release is ...

CBSE Class 12 Syllabus 2026–27 provides a clear guide for students across all streams to plan their studies effectively. Following the syllabus properly can help improve preparation and boost ...

Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...